HRMY - Harmony Biosciences Holdings Inc
28.79
0.050 0.174%
Share volume: 544,083
Last Updated: 03-11-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.16%
PREVIOUS CLOSE
CHG
CHG%
$28.74
0.05
0.00%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 09-30-2025 | 12-31-2025 | |
|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q3 2025 | Q4 2025 | |
| Report Date | 04-30-2024 | 08-06-2024 | 10-29-2024 | 02-25-2025 | 05-06-2025 | 11-04-2025 | 02-24-2026 | |
| Cash flow financing | -3.634 M | -3.446 M | -1.175 M | -2.741 M | -352.000 K | -2.996 M | -3.015 M | |
| Other financing cash flows | 116.000 K | 304.000 K | 2.575 M | 1.009 M | 3.398 M | 754.000 K | 1.985 M | |
| Cash flow | 21.321 M | -15.685 M | 70.071 M | 65.634 M | 35.997 M | 100.949 M | 105.503 M | |
| Net income | 38.334 M | 11.591 M | 46.093 M | 49.475 M | 45.560 M | 50.865 M | 22.486 M | |
| Depreciation | 163.000 K | 91.000 K | 7.000 K | 6.000 K | 7.000 K | 7.000 K | 0.000 | |
| Changes in inventories | 494.000 K | 0.000 | 0.000 | 0.000 | -814.000 K | 0.000 | 0.000 | |
| Changes in receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Investing Cashflow | -6.186 M | -54.856 M | 745.000 K | -7.187 M | 2.362 M | -4.789 M | -17.633 M | |
| Net Borrowings | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Investing Activity Other | 0.000 | 0.000 | 0.000 | -1.000 M | 0.000 | 0.000 | -19.250 M | |
| Dividends Paid | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Exchange Rate Effect | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Capital Expenditures | 5.000 K | 632.000 K | 3.000 K | 33.582 M | 128.000 K | 71.000 K | 107.000 K | |
| Cash Change | 21.321 M | -15.685 M | 70.071 M | 65.634 M | 35.997 M | 100.949 M | 105.503 M |